(MCHN) Invesco MSCI China All - Ratings and Ratios
Chinese, Stocks, Bonds
Description: MCHN Invesco MSCI China All
The Invesco MSCI China All Shares Connect UCITS ETF EUR (Ticker: MCHN) is a Germany-domiciled ETF listed on XETRA, designed to provide exposure to Chinas equity market, including A-shares, which are renminbi-denominated stocks traded on the Shanghai and Shenzhen stock exchanges. The fund is UCITS-compliant, making it accessible to European investors seeking diversified access to Chinese equities. It tracks the Morningstar China TME NR USD Index, which includes large- and mid-cap companies across various sectors in China.
The ETFs technical indicators suggest a mixed near-term outlook. With an average 20-day volume of 1028 shares, trading activity remains low, indicating limited liquidity. The last price of 25.49 EUR is slightly below the 20-day SMA of 25.55 and above the 50-day SMA of 24.33, signaling a potential short-term consolidation phase. The 200-day SMA of 22.09 reflects longer-term upward momentum. The ATR of 0.38 indicates relatively low volatility compared to broader market indices.
From a fundamental perspective, the ETFs assets under management (AUM) of 50.08M EUR suggest a modest-sized fund, which may appeal to investors seeking targeted exposure to Chinas equity market without excessive capital allocation. The funds structure allows for diversification across key sectors in China, including technology, financials, and consumer discretionary, aligning with the countrys economic growth drivers.
3-Month Forecast: Based on the intersection of technical and fundamental data, the ETF is likely to experience sideways to slightly bearish movement in the near term. The convergence of SMAs and low ATR suggests limited upside momentum, while the broader macroeconomic environment, including Chinas economic recovery pace and global risk sentiment, will remain key drivers. Upside potential may emerge if Chinas equity market gains traction, while downside risks could stem from regulatory uncertainties and geopolitical tensions.
Additional Sources for MCHN ETF
MCHN ETF Overview
Market Cap in USD | 59m |
Category | China Equity |
TER | 0.35% |
IPO / Inception | 2021-03-01 |
MCHN ETF Ratings
Growth Rating | -20.9 |
Fundamental | - |
Dividend Rating | 0.0 |
Rel. Strength | -8.4 |
Analysts | - |
Fair Price Momentum | 22.17 EUR |
Fair Price DCF | - |
MCHN Dividends
Currently no dividends paidMCHN Growth Ratios
Growth Correlation 3m | 41.9% |
Growth Correlation 12m | 57.1% |
Growth Correlation 5y | -62.5% |
CAGR 5y | -5.87% |
CAGR/Max DD 5y | -0.13 |
Sharpe Ratio 12m | -0.06 |
Alpha | 7.80 |
Beta | 0.492 |
Volatility | 18.02% |
Current Volume | 0.8k |
Average Volume 20d | 0.4k |
Stop Loss | 22.9 (-3.7%) |
As of July 09, 2025, the stock is trading at EUR 23.77 with a total of 809 shares traded.
Over the past week, the price has changed by +0.87%, over one month by -1.53%, over three months by +9.49% and over the past year by +19.42%.
Neither. Based on ValueRay´s Analyses, Invesco MSCI China All is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -20.88 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of MCHN is around 22.17 EUR . This means that MCHN is currently overvalued and has a potential downside of -6.73%.
Invesco MSCI China All has no consensus analysts rating.
According to our own proprietary Forecast Model, MCHN Invesco MSCI China All will be worth about 24.9 in July 2026. The stock is currently trading at 23.77. This means that the stock has a potential upside of +4.67%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 24.9 | 4.7% |